ダウンロード数: 56

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
KURNS_PR2020_173.pdf2.59 MBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.date.accessioned2021-08-30T05:17:00Z-
dc.date.available2021-08-30T05:17:00Z-
dc.date.issued2021-08-
dc.identifier.urihttp://hdl.handle.net/2433/264997-
dc.descriptionIn case that corrections are made, an errata will be provided in the following webpage: https://www.rri.kyoto-u.ac.jp/PUB/report/PR/ProgRep2020/ProgRep2020.htmlen
dc.description.tableofcontentsCO7-1 Establichment of a novel mutation breeding using Boron Neutron Capture Reaction (BNCR) /M. Kirihata et al. (R2015) [173]en
dc.description.tableofcontentsCO7-2 Development of antibody-tagged boron compounds using Fc-binding peptide for on-demand receptor target in boron neutron capture therapy /I. Nakase et al. (R2016) [174]en
dc.description.tableofcontentsCO7-3 Development of cyclic RGD-functionalized closo-dodecaborate albumin conjugates for boron neutron capture therapy /H. Nakamura et al. (R2021) [175]en
dc.description.tableofcontentsCO7-4 Development of closo-dodecaborate-containing pteroyl derivatives targeting folate receptor-positive tumors for boron neutron capture therapy /H. Nakamura et al. (R2022) [176]en
dc.description.tableofcontentsCO7-5 Influence of the abscopal effect to the survival rate following head neutron-irradiation between the different inbred mice /Y. Kinashi et al. (R2023) [177]en
dc.description.tableofcontentsCO7-6 Optimization of chemical structures of polymer-BPA complexes for a nonclinical study /T. Nomoto et al. (R2035) [178]en
dc.description.tableofcontentsCO7-7 OKD-001-based BNCT successfully prolongs the overall survival of orthotopic xenograft mouse model of a patient-derived glioblastoma stem-like cell line /A. Fujimura et al. (R2039) [179]en
dc.description.tableofcontentsCO7-8 Enhancement of the cancer cell-killing effects of boron neutron capture therapy by overexpression of LAT1 in human cancer cells /K. Ohnishi et al. (R2041) [180]en
dc.description.tableofcontentsCO7-9 Mechanism of Glioma Stem Cells’ Survival Conferred by Glioma Niche after BNCT /N. Kondo et al. (R2059) [181]en
dc.description.tableofcontentsCO7-10 Establishment of protocol for neutron capture therapy for head and neck cancer /I. Ota et al. (R2060) [182]en
dc.description.tableofcontentsCO7-11 Identification of host immunostimulatory effects induced by boron neutron capture therapy /T. Watanabe et al. (R2088) [183]en
dc.description.tableofcontentsCO7-12 Preliminary study of antitumor effectivity by Gd-neutron capture therapy using RGD binding Gd-DTPA-incorporated calcium phosphate nanoparticles to canine hemangiosarcoma model /M. Yanagawa et al. (R2089) [184]en
dc.description.tableofcontentsCO7-13 Screening of boron compounds for BNCT on 2020 International collaboration studies /M. Takagaki et al. (R2118) [185]en
dc.description.tableofcontentsCO7-14 The evaluation of boron neutron capture therapy (BNCT) to the novel mouse model of pelvic recurrence of colorectal cancer /J. Arima et al. (R2135) [186]en
dc.description.tableofcontentsCO7-15 Self-assembling A6K peptide nanotubes for BSH delivery /H. Michiue et al. (R2136) [187]en
dc.description.tableofcontentsCO7-16 Experiment on BNCR Effect of a Novel BPA Formulation using Ionic Liquid by Thermal Neutron Irradiation /M. Shirakawa et al. (R2142) [188]en
dc.description.tableofcontentsCO7-17 Application of Intra-Tumoral Injection of Gadolinium-Polyplex for Gadolinium-Neutron Capture Therapy to Pancreatic Cancer Model in vivo /H.Yanagie et al. (R2144) [189]en
dc.description.tableofcontentsCO7-18 Functionalization of Boron-Containing Nanoparticle and its Application to Boron Neutron Capture Therapy /Y. Wang et al. (R2148) [190]en
dc.description.tableofcontentsCO7-19 Basic research to expand the application of BNCT to companion animals /Y. Wada and M. Suzuki (R2151) [191]en
dc.description.tableofcontentsCO7-20 Development of real-time boron-concentration estimation system for whole-organirradiation BNCT /Y. Sakurai et al. (R2153) [192]en
dc.description.tableofcontentsCO7-21 Development of ¹⁰Boron-loaded silica nanoparticles for BNCT application /F. Tamanoi et al. (R2155) [193]en
dc.description.tableofcontentsCO7-22 Three dimentional model for pre-clinical investigations in BNCT /K. Igawa et al. (R2162) [194]en
dc.description.tableofcontentsCO7-23 A novel carbon nanohorns for BNCT in vitro study /T. Tsurubuchi et al. (R2167) [195]en
dc.description.tableofcontentsCO7-24 Development of ¹⁰BPA-loaded mesoporous silica-based nanoparticles and preliminary evaluation in BNCT mouse experiments /F. Tamanoi et al. (R2170) [196]en
dc.description.tableofcontentsCO7-25 Effects of overexpression of LAT1 on suppression of tumor growth by boron neutron capture therapy /K. Ohnishi et al. (R2173) [197]en
dc.description.tableofcontentsCO7-26 Synthesis of a Novel Boron Compound with Potential Peptide-Related Nuclear Import /M. Shirakawa et al. (R2174) [198]en
dc.language.isoeng-
dc.publisherInstitute for Integrated Radiation and Nuclear Science, Kyoto Universityen
dc.publisher.alternative京都大学複合原子力科学研究所ja
dc.subject.ndc539-
dc.title7. Neutron Capture Therapyen
dc.typearticle-
dc.type.niitypeArticle-
dc.identifier.jtitleKURNS Progress Reporten
dc.identifier.volume2020-
dc.identifier.spage173-
dc.identifier.epage198-
dc.textversionpublisher-
dc.sortkey15-
dc.relation.urlhttps://www.rri.kyoto-u.ac.jp/PUB/report/PR/ProgRep2020/ProgRep2020.html-
dcterms.accessRightsopen access-
dcterms.alternativeI. ANNUAL SUMMARY OF EXPERIMENTAL RESEARCH ACTIVITIES. I-2. COLLABORATION RESEARCHESen
dc.identifier.pissn2434-9488-
dc.identifier.eissn2434-947X-
出現コレクション:2020

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。